Colitis ulcerosa: risks of discontinuing treatment

Professor Chris Probert talks about the current state of research and presents results of a recent study on clinical efficacy and patient safety of Golimumanb for induction and maintenance in patients with moderate to severe colitis ulcerosa.

The treatment of colitis ulcerosa presents many challenges. Professor Chris Probert talks about the current state of research and presents results of a recent study on clinical efficacy and patient safety of Golimumanb for induction and maintenance in patients with moderate to severe colitis ulcerosa.

Click HERE for further information about chronic inflammatory bowel disease.